Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,018.00
Bid: 12,016.00
Ask: 12,020.00
Change: 88.00 (0.74%)
Spread: 4.00 (0.033%)
Open: 12,108.00
High: 12,142.00
Low: 11,994.00
Prev. Close: 11,930.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-EU stokes anger with plan to restrict vaccine exports through Irish border

Fri, 29th Jan 2021 19:28

* EU triggers Brexit clauses

* EU tries to restrict vaccine exports to UK

* UK seeks urgent answers, expresses concern

* Irish PM expresses concerns to EU chief
(Adds latest comment from Johnson, report that EU has U-turned)

By Andy Bruce, Kate Holton and Marine Strauss

LONDON/BRUSSELS, Jan 29 (Reuters) - The European Union on
Friday sought to restrict exports of COVID-19 vaccines through
the Irish border to the United Kingdom by invoking emergency
clauses in the Brexit divorce deal, sending shockwaves through
both Ireland and Northern Ireland.

In a steep escalation of the EU's fight to secure vaccine
supplies, the EU triggered clauses in the Northern Irish
Protocol that would limit the supply of vaccines crossing the
Irish border into the United Kingdom.

Northern Irish unionists cast the move as an act of
hostility while Irish Prime Minister Micheál Martin sought
urgent clarification from European Commission President Ursula
von der Leyen.

As Britain considered its response, British Prime Minister
Boris Johnson said the EU had to clarify its intentions to
ensure it honoured its commitments to Northern Ireland.

"He expressed his grave concerns about the potential impact
which the steps the EU has taken today on vaccine exports could
have," Johnson's office said in a readout of a phone call
between Johnson and von der Leyen.

It was not immediately clear if the move to invoke the
article, set out in a document published on Friday, would come
into effect immediately - or indeed if it was some sort of
mistake.

A link to the document was no longer working at 2050 GMT.

A Sky News reporter said the EU had withdrawn its move to
override the Northern Irish treaty. Euronews said the whole
thing was a 'mistake' and an 'oversight'.

The Commission did not comment when contacted by Reuters for
clarification but was expected to make a statement shortly.

The swiftest mass vaccination drive in history is stoking
tensions across the world as big powers buy up doses in bulk and
poorer nations try to navigate a financial and diplomatic
minefield to collect whatever supplies are left.

IRISH BORDER

Preserving the delicate peace in Northern Ireland without
allowing the United Kingdom a back door into the EU's markets
through the UK-Irish 310-mile land border was one of the most
difficult issues of the Brexit divorce talks.

The EU's action - even if it rescinds the decision -
triggered anger.

Northern Ireland First Minister Arlene Foster described as
"an incredible act of hostility" the decision by the EU to
invoke Article 16 of the Northern Irish Protocol, which allows
Britain or the EU to take unilateral action if there is an
unexpected negative effect arising from the agreement.

"The European Union has once again shown it is prepared to
use Northern Ireland when it suits their interests but in the
most despicable manner – over the provision of a vaccine which
is designed to save lives," Foster said.

The EU move is designed to prevent the open border between
EU-member Ireland and Northern Ireland from acting as a backdoor
for vaccine supplies into the United Kingdom.

Article 16 was devised as a last resort to alleviate serious
disruption to trade in Northern Ireland after Brexit.

The EU, whose member states are far behind Israel, Britain
and the United States in rolling out vaccines, is scrambling to
get supplies just as the West's biggest drugmakers slow
deliveries to the bloc due to production problems.

The British-Swedish drugmaker AstraZeneca has been
caught in the crosshairs after it said last week it would fall
short of delivering promised vaccines to the EU by March because
of production problems in Belgium.

That has angered Brussels which has demanded to know why it
cannot divert supplies from its British sites which have been
producing millions of shots for British citizens.

The European Commission has agreed a plan to control exports
of vaccines from the bloc, including to Britain, arguing it
needed to do so to ensure its own supplies.

The Commission said its move to invoke Article 16 was
justified to "avert serious societal difficulties" in EU states
due to a lack of vaccine supply, the document published on
Friday said.

Britain has its own domestic supply chain in place for
AstraZeneca's shot, including rolling it out in Northern
Ireland, but it imports Pfizer's vaccine from a factory in
Belgium.

Britain had threatened to trigger the Article 16 safeguard
measures earlier in the month if there were "serious problems"
in supplying supermarkets in Northern Ireland.
(Reporting by Kate Holton, Andy Bruce and William James;
Editing by Guy Faulconbridge and Daniel Wallis)

More News
Today 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
Today 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.